When a physician’s family gets trapped in the labyrinth of American healthcare, the fallout can reshape entire industries. For Danish Nagda, MD, watching his father suffer a preventable heart attack after years of misdiagnosis sparked not just grief, but a blueprint for a new kind of medical practice.
Dr. Nagda became his father’s full-time caregiver while still grinding through an otolaryngology residency. Shuftling between appointments, battling a system that failed an insured patient, he glimpsed a different path forward: rebuilding healthcare on a digital chassis. That vision eventually materialized as Rezilient Health.
The company’s flagship concept, CloudClinics, places community-based medics in physical offices while physician specialists beam in remotely. Those clinicians direct the hands-on care via connected digital tools. For patients, that translates into same-day primary and specialty visits without the usual scheduling nightmares.
Time tells the story. Rezilient members average 31 minutes with a provider. Traditional primary care clocks in around 14.7 minutes. As a result, the company reports fewer emergency department visits, stronger medication management, and reduced hospitalizations. Employers win too, since the model drives down overall health spending.
Dr. Nagda leads the company as CEO and no longer sees patients. He will, however, share hard-won startup lessons at the AMA Physician Entrepreneur Forum in Chicago on Aug. 7 and 8. Among them: true entrepreneurship bears little resemblance to the fantasy. Founders never actually work for themselves. Patients, board members, and investors all demand accountability. The payoff arrives when the machine hums along without its creator.
He also filters for a specific temperament. The physician entrepreneur tends to be the colleague constantly questioning entrenched routines, never satisfied with “that’s just how we do it.” Yet curiosity alone falls short without its twin: a bias toward building something new. That compulsion to act separates tinkerers from founders.
Another piece of guidance cuts deeper. Dr. Nagda urges early-stage builders to obsess over the problem, not the solution. Too many clinicians chase shiny fixes without validating the underlying pain point or sizing the opportunity. A billion-dollar problem demands different financing decisions than a hundred-million-dollar headache. Customers, meanwhile, need evidence that the problem truly resonates before they buy into any answer.
